Medifast (MED) Tops Q1 EPS by 12c, Misses on Revenue

Medifast (NYSE: MED) reported Q1 EPS of ($0.07), $0.12 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $115.7 million versus the consensus estimate of $130.75 million.

GUIDANCE:

Medifast sees Q2 2025 revenue of $85-105 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low